NEW YORK (Reuters) - Eli Lilly said on Thursday U.S. regulators approved the use of Cymbalta, its blockbuster anti-depressant drug, for chronic musculoskeletal pain, including lower back pain and ...

The U.S. Food and Drug Administration has approved Cymbalta for chronic back pain and osteoarthritis pain, according to a FDA news release. Cymbalta, which was first used to treat major depressive ...

CHICAGO (Reuters) - Eli Lilly and Co said on Friday it withdrew an application to market its anti-depressant Cymbalta for the management of chronic pain because U.S. health regulators raised questions ...

NEW YORK (MarketWatch) -- Eli Lilly and Co. said Monday that the U.S. Food and Drug Administration has approved its Cymbalta drug for the management of fibromyalgia, a chronic widespread pain disorder ...

The FDA has approved duloxetine (Cymbalta) to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic low-back pain. Several recent randomized trials have evaluated ...

The medication -used for nerve pain and depression- has been found with impurities, according to the Federal Drug Administration.

Everything else fades away when we’re in pain. The small stresses of daily life stop mattering, and our focus narrows to the discomfort we’re feeling. And make no mistake, that pain is real. Research ...